{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:18:01Z","timestamp":1783174681186,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["202104J07020029"],"award-info":[{"award-number":["202104J07020029"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["20YF1459200"],"award-info":[{"award-number":["20YF1459200"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403243"],"award-info":[{"award-number":["82403243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572350"],"award-info":[{"award-number":["81572350"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.drup.2026.101417","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:07:31Z","timestamp":1780013251000},"page":"101417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RAD1 promotes oxaliplatin resistance in gastric cancer by reinforcing NRF2-driven antioxidant defense and DDR checkpoint signaling"],"prefix":"10.1016","volume":"87","author":[{"given":"Baichuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhemin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiwen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3862-1239","authenticated-orcid":false,"given":"Zhixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101417_bib1","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat. Med."},{"key":"10.1016\/j.drup.2026.101417_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41571-025-01003-3","article-title":"Emerging clinical applications of single-cell RNA sequencing in oncology","volume":"22","author":"Boxer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101417_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1126\/science.adh3694","article-title":"RHINO directs MMEJ to repair DNA breaks in mitosis","volume":"381","author":"Brambati","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.drup.2026.101417_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/annonc\/mdw040","article-title":"Molecular classification of gastric cancer","volume":"27","author":"Chia","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2026.101417_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2026.101417_bib6","first-page":"21","article-title":"The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy","volume":"11","author":"Feng","year":"2024","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.drup.2026.101417_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101417_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.drup.2026.101417_bib9","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101417_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/path.6400","article-title":"PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer","volume":"265","author":"Harada","year":"2025","journal-title":"J. Pathol."},{"key":"10.1016\/j.drup.2026.101417_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","article-title":"Artificial intelligence-based multi-omics analysis fuels cancer precision medicine","volume":"88","author":"He","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2026.101417_bib12","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1200\/JCO.23.01889","article-title":"Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial","volume":"42","author":"Hu","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101417_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.drup.2026.101417_bib14","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1038\/s41388-024-03117-x","article-title":"RHNO1: at the crossroads of DNA replication stress, DNA repair, and cancer","volume":"43","author":"Jirapongwattana","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101417_bib15","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2026.101417_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-025-02328-4","article-title":"The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates","volume":"24","author":"Kan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101417_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202200084","article-title":"Single cell RNA-sequencing: A powerful yet still challenging technology to study cellular heterogeneity","volume":"44","author":"Ke","year":"2022","journal-title":"Bioessays"},{"key":"10.1016\/j.drup.2026.101417_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","article-title":"Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer","volume":"12","author":"Kumar","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2026.101417_bib19","article-title":"Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.drup.2026.101417_bib20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gutjnl-2024-332901","article-title":"Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages","volume":"74","author":"Lee","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.drup.2026.101417_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101201","article-title":"Organoid models of drug resistant gastric adenosquamous carcinoma: Recapitulating tumor features and refining precision treatment","volume":"79","author":"Li","year":"2025","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101417_bib22","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1186\/s12889-024-19104-6","article-title":"Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035","volume":"24","author":"Lin","year":"2024","journal-title":"BMC Public. Health"},{"key":"10.1016\/j.drup.2026.101417_bib23","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.csbj.2024.06.035","article-title":"Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection","volume":"23","author":"Liu","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.drup.2026.101417_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116310","article-title":"Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives","volume":"173","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.drup.2026.101417_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217731","article-title":"COL1A1-positive endothelial cells promote gastric cancer progression via the ANGPTL4-SDC4 axis driven by endothelial-to-mesenchymal transition","volume":"623","author":"Liu","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101417_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.drup.2026.101417_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41571-021-00492-2","article-title":"Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm","volume":"18","author":"Nakamura","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101417_bib28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.gtc.2022.05.001","article-title":"Gastric Cancer: Emerging Trends in Prevention, Diagnosis, and Treatment","volume":"51","author":"Norwood","year":"2022","journal-title":"Gastroenterol. Clin. North. Am."},{"key":"10.1016\/j.drup.2026.101417_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100796","article-title":"Anticancer drug resistance: An update and perspective","volume":"59","author":"Nussinov","year":"2021","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101417_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000676","article-title":"Oncogenic pathway combinations predict clinical prognosis in gastric cancer","volume":"5","author":"Ooi","year":"2009","journal-title":"PLoS. Genet."},{"key":"10.1016\/j.drup.2026.101417_bib31","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: Emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101417_bib32","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.drup.2026.101417_bib33","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.cell.2024.04.032","article-title":"A developmental constraint model of cancer cell states and tumor heterogeneity","volume":"187","author":"Patel","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101417_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/2159-8290.CD-17-0395","article-title":"Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma","volume":"8","author":"Pectasides","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2026.101417_bib35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101417_bib36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s13304-020-00751-4","article-title":"Patient-Derived Orthotopic Xenograft models in gastric cancer: a systematic review","volume":"72","author":"Reddavid","year":"2020","journal-title":"Updates Surg."},{"key":"10.1016\/j.drup.2026.101417_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2026.101417_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114811","article-title":"Single-cell RNA sequencing and bioinformatics as tools to decipher cancer heterogenicity and mechanisms of drug resistance","volume":"195","author":"Rosati","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2026.101417_bib39","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/jnci\/djp335","article-title":"Use of archived specimens in evaluation of prognostic and predictive biomarkers","volume":"101","author":"Simon","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2026.101417_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2021.101599","article-title":"Multidisciplinary treatment strategy for locally advanced gastric cancer: A systematic review","volume":"38","author":"Sugawara","year":"2021","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.drup.2026.101417_bib41","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1038\/s41467-022-32627-z","article-title":"scRNA-seq of gastric tumor shows complex intercellular interaction with an alternative T cell exhaustion trajectory","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101417_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173663","article-title":"Evaluations of primary lesions by endoscopy clearly distinguishes prognosis in patients with gastric cancer who receive chemotherapy","volume":"12","author":"Tahara","year":"2017","journal-title":"PLoS. One"},{"key":"10.1016\/j.drup.2026.101417_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113370","article-title":"Treatment of gastric adenocarcinoma: A rapidly evolving landscape","volume":"195","author":"Taieb","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2026.101417_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102019","article-title":"Review of precision cancer medicine: Evolution of the treatment paradigm","volume":"86","author":"Tsimberidou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.drup.2026.101417_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104197","article-title":"Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer","volume":"198","author":"Wang","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.drup.2026.101417_bib46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.trecan.2022.04.006","article-title":"Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy","volume":"8","author":"Witkiewicz","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2026.101417_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data","volume":"8","author":"Wolock","year":"2019","journal-title":"Cell. Syst."},{"key":"10.1016\/j.drup.2026.101417_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101275","article-title":"Hypoxia-induced upregulation of HIF1A-AS3 promotes MSC transition to cancer-associated fibroblasts and confers drug resistance in gastric cancer","volume":"82","author":"Xu","year":"2025","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101417_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217617","article-title":"Organoid-based single cell sequencing revealed the lineage evolution during docetaxel treatment in gastric cancer","volume":"619","author":"Yang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101417_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47030172","article-title":"Multi-Pathway Study for Oxaliplatin Resistance Reduction","volume":"47","author":"Ye","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.drup.2026.101417_bib51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12885-020-06814-4","article-title":"Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB\/c nude mice model","volume":"20","author":"Yoon","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2026.101417_bib52","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2026.101417_bib53","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","article-title":"Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.drup.2026.101417_bib54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1574892816666210929165729","article-title":"Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review","volume":"17","author":"Zhang","year":"2022","journal-title":"Recent. Pat. Anticancer. Drug. Discov."},{"key":"10.1016\/j.drup.2026.101417_bib55","article-title":"Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer","volume":"5","author":"Zhao","year":"2024","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.drup.2026.101417_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12943-025-02449-w","article-title":"BRD9-p53-E2F1 circuit orchestrates cell growth and DNA damage repair in gastric cancer","volume":"24","author":"Zhou","year":"2025","journal-title":"Mol. Cancer"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:38:08Z","timestamp":1783172288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"alternative-id":["S1368764626000683"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101417","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAD1 promotes oxaliplatin resistance in gastric cancer by reinforcing NRF2-driven antioxidant defense and DDR checkpoint signaling","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101417"}}